Detalles de la búsqueda
1.
Effect of vedolizumab (anti-α4ß7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.
Gut
; 67(1): 43-52, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27802155
2.
The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.
Crit Rev Biochem Mol Biol
; 51(5): 295-358, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27362691
3.
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(12): 1937-1946.e8, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29704680
4.
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.
Gut
; 66(1): 79-88, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26423113
5.
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?
Gut
; 68(8): 1531-1533, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30007919
6.
Epithelial organoid cultures from patients with ulcerative colitis and Crohn's disease: a truly long-term model to study the molecular basis for inflammatory bowel disease?
Gut
; 66(12): 2193-2195, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28159838
7.
The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
J Crohns Colitis
; 14(2): 176-184, 2020 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628842
8.
Comparisons of gut microbiota profiles in wild-type and gelatinase B/matrix metalloproteinase-9-deficient mice in acute DSS-induced colitis.
NPJ Biofilms Microbiomes
; 4: 18, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181895
9.
NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.
Expert Opin Ther Targets
; 21(12): 1123-1139, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096557
10.
Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.
Nat Commun
; 8: 15384, 2017 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28561062
11.
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis.
J Crohns Colitis
; 10(11): 1336-1350, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27194531
12.
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
J Crohns Colitis
; 9(12): 1079-87, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26351381
13.
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
J Crohns Colitis
; 9(12): 1120-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26351386
14.
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
Inflamm Bowel Dis
; 20(7): 1198-207, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24871805
15.
Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel disease.
Inflamm Bowel Dis
; 20(2): 339-52, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24378596
16.
Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies.
J Crohns Colitis
; 12(9): 1011-1013, 2018 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010739
Resultados
1 -
16
de 16
1
Próxima >
>>